All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YY2733 | Anti-ITGA7 (CBYY-I0264) h(41BB-CD3ζ) CAR, pCDCAR1 | CBYY-I0264 | Rat | scfv-41BB-CD3ζ | Retroviral | T cell | |||
CAR-YY3100 | Anti-ITGA7 (CBYY-I0264) h(CD28-CD3ζ) CAR, pCDCAR1 | CBYY-I0264 | Rat | scfv-41BB-CD3ζ | Retroviral | T cell | |||
CAR-LY3293 | Anti-ITGA7 (1F4) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Human | 1F4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3294 | Anti-ITGA7 (334908) h(41BB-CD3ζ) CAR, pCDCAR1 | 334908 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY3295 | Anti-ITGA7 (3C12) h(41BB-CD3ζ) CAR, pCDCAR1 | 3C12 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY3296 | Anti-ITGA7 (6A11) h(41BB-CD3ζ) CAR, pCDCAR1 | 6A11 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY3297 | Anti-ITGA7 (8G2) h(41BB-CD3ζ) CAR, pCDCAR1 | 8G2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY3431 | Anti-ITGA7 (1F4) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Human | 1F4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3432 | Anti-ITGA7 (334908) h(CD28-CD3ζ) CAR, pCDCAR1 | 334908 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY3433 | Anti-ITGA7 (3C12) h(CD28-CD3ζ) CAR, pCDCAR1 | 3C12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY3434 | Anti-ITGA7 (6A11) h(CD28-CD3ζ) CAR, pCDCAR1 | 6A11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY3435 | Anti-ITGA7 (8G2) h(CD28-CD3ζ) CAR, pCDCAR1 | 8G2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION